AI in drug discovery and diagnostics at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
43 organizations at FoG London 2027 present work in AI in drug discovery & diagnostics, led by universities and research institutes. Between them they bring 122 presentations to the program. Most represented: University of Oxford, Wellcome Sanger Institute and Queen Mary University of London. As of Oct 29, 2026.
Format
Top represented
Showing 1–4 of 43 organizations
| Organization | FoG London 2027 Attendance |
|---|---|
University of Oxford Oxford, UK | |
Collegiate research university in Oxford, England, whose Medical Sciences Division spans human genetics, population health and clinical research. | Talk Wed Jan 27 11:30–12:00 Why Do We Sleep? Why animals evolved to sleep, how light and body clocks time it, and how shift work and jet lag disrupt health. Population & social genomics Talk Wed Jan 27 12:30–13:00 Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance Why tracking bacterial outbreaks needs gene-by-gene genome comparison rather than human genetics methods, shown through an outbreak of meningococcal disease in Kent. Talk Wed Jan 27 14:30–15:00 Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics New ways to deliver advanced therapies, including pulsed and long-acting release systems, microrobots and new tools for measuring nanoparticles. Talk Wed Jan 27 14:30–15:00 Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation Why tests for drug-resistant infections and newborn sepsis in low- and middle-income countries depend on cost and infrastructure, and how genomics tracks spread. Talk Wed Jan 27 16:30–17:00 Accelerating the Development of Therapies for Rare Genetic Disease How a transatlantic partnership brings expertise and investment to preclinical drug projects for rare genetic diseases. Talk Wed Jan 27 16:30–17:00 The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines How genomic discoveries, national supercomputers and self-running laboratories are letting AI design new medicines based on genetics. Talk Wed Jan 27 16:30–17:00 The Body Clock in Your Blood: Circadian Signals in Omics Research How proteins and metabolites in one blood sample can reveal a person's body-clock time, and why time of day skews biomarker studies. Talk Wed Jan 27 17:30–18:00 Using Pathogen Genomics to Inform Vaccine Strategy and Public Health Response How international lab data on invasive bacterial disease track post-pandemic shifts in bacterial strains and what they mean for vaccines. Talk Thu Jan 28 11:30–12:00 Harnessing Bacterial Competition to Prevent Disease in the Gut Microbiome How finding the gut bacteria that best outcompete pathogens can guide the design of protective microbial mixtures. Talk Thu Jan 28 12:30–13:00 Deciphering Mammalian Morphogenesis - A Single-Cell Phenomic Perspective How tracking single cells' molecules, shape and behaviour in early mammalian embryos shows how the front end is patterned and the heart starts beating. Panel Thu Jan 28 14:10–14:40 Is Modern Life Fighting Our Human Biology? Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity. Population & social genomics Talk Thu Jan 28 14:10–14:40 Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing Why first-generation multi-cancer blood tests fall short, and how AI analysis of several features of tumour DNA in the blood could improve them. Talk Thu Jan 28 14:10–14:40 Quantum Computing & The Future of Genomic Data: From Single Genomes to Pangenomes How a virus genome encoded on a quantum computer points to new ways of analysing pangenomes, reference sets built from many genomes. Talk Thu Jan 28 14:10–14:40 Why Endometriosis Is Not One Disease: Insights from Genetics How large genetic studies split endometriosis into distinct subtypes, link it to ovarian and endometrial cancers and point to new treatment targets. Workshop Thu Jan 28 14:10–15:40 Making Sense of Multi-Omic Data: Scalable Analysis and Interpretation Multi-omics & proteomics Talk Thu Jan 28 14:40–15:10 Talk Thu Jan 28 15:10–15:40 Utilising Multi-omic Integration & Machine Learning for the Better Understanding of Disease: Painful and Painless Peripheral Neuropathy Example How combining genetic, gene expression, protein and metabolite markers could explain why only some people with nerve damage develop lasting pain. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Talk Thu Jan 28 16:10–16:40 Single-Cell & Spatial Multi-Omics to Decrypt Intestinal Development How a cell-by-cell map of the developing human gut tracks its maturation and why preterm birth may impair it. Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease Talk Thu Jan 28 16:40–17:10 Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease How repeated tissue biopsies from treated patients, read cell by cell, reveal how drugs act on inflammatory diseases and why some stop working. Talk Thu Jan 28 16:40–17:10 Leveraging Big Data to Inform Cardiovascular Precision Medicine How combining genomic, clinical and real-world patient data can identify cardiovascular disease risk and guide more targeted prevention and treatment. |
Wellcome Sanger Institute Hinxton, UK | |
Genomics research institute sequencing and studying genomes in human health, cancer, pathogens and biodiversity. | Talk Wed Jan 27 11:30–12:00 Rethinking Cholera - How Genomics Transformed Our Understanding of a Global Pandemic How genomics overturned old ideas about how cholera spreads and persists, and why tracking it needs global, fairly shared data. Talk Wed Jan 27 12:30–13:00 Pregnancy as a Window into Immune and Disease Biology How repeated RNA sequencing through pregnancy tracks immune changes, and whether pre-eclampsia and preterm birth carry distinct molecular signatures. Talk Wed Jan 27 12:30–13:00 Taking Single Cell mRNA Sequencing to the Bedside How the Human Cell Atlas, which defines cell types by their mRNA, could help bring single-cell mRNA sequencing into clinical care. Talk Wed Jan 27 12:30–13:00 Towards Nucleotide Resolution Genomic Medicine: Scaling MAVEs How lab experiments that test huge numbers of DNA variants at once build function maps for interpreting genetic test results and training AI. Talk Wed Jan 27 15:30–16:00 Cell-Type-Specific Isoform Dysregulation in Crohn's Disease: Insights from Single-Cell Long-Read Sequencing How single-cell long-read sequencing of gut cells finds cell-type-specific splicing in Crohn's disease that may explain puzzling genetic risk regions. Single-cell genomics Talk Wed Jan 27 16:30–17:00 Single-Cell & Spatial to Decode Tissue Biology Through the Lens of Women's Health How single-cell and spatial maps of the ovaries, fallopian tubes and uterus reveal how their cells are organised and improve lab-grown models. Workshop Wed Jan 27 16:30–18:00 Panel Wed Jan 27 17:30–18:00 Choosing the Right Sequencing Technology: Short Reads, Long Reads & Beyond How researchers weigh short-read and long-read sequencing on accuracy, resolution, throughput and cost, and when to combine them. Talk Thu Jan 28 11:30–12:00 Decoding the Tissue Ecosystems of the Human Body How single-cell, spatial and AI methods are building reference maps of the developing human body and revealing how cells form tissue neighbourhoods. Talk Thu Jan 28 16:10–16:40 From Microbiome Data to Live Biotherapeutics: Turning Gut Bacteria into Medicine How gut bacteria linked to how patients respond are developed into living medicines, with recent progress in ulcerative colitis and manufacturing hurdles. |
Queen Mary University of London London, UK | |
London research university with genomic medicine, computational biology, clinical pharmacology and population health research. | Talk Wed Jan 27 11:30–12:00 AI Agents for Rare Disease Diagnosis: Accelerating Variant Interpretation in Clinical Genomics How AI agents and large language models can speed up interpreting genetic variants for rare disease diagnosis within NHS genomic services. Talk Wed Jan 27 11:30–12:00 Pharmacogenomics in Healthcare How health systems could adopt pharmacogenomics, testing genes to guide prescribing, and whether to test in advance or only when needed. Talk Wed Jan 27 11:30–12:00 Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing How unusually low blood protein levels could help diagnose rare disease patients left undiagnosed after whole-genome sequencing, and flag new disease genes. Talk Wed Jan 27 11:30–13:00 Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes AI in drug discovery & diagnostics Talk Wed Jan 27 15:30–16:00 Telomere Biology Disorders: Insights into Early-Life Programming and Lifelong Disease Risk How rare congenital disorders show why telomeres, the protective caps on chromosome ends, matter early in life and shape lifelong disease risk. Talk Thu Jan 28 14:10–14:40 From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care How population genomic testing can find people at higher risk of women's cancers and guide targeted screening and prevention. Talk Thu Jan 28 15:10–15:40 A Human DNA Methylation Atlas for Epigenomic Interpretation How an atlas of DNA methylation marks across healthy human cell types helps interpret epigenetic data and cell-free DNA in blood. Talk Thu Jan 28 16:40–17:10 Rethinking Monogenic DIsease in the Era of Population Genomics How population-scale genome data and new ways to detect repeated DNA sequences are changing how single-gene diseases are understood. |
University of Edinburgh Edinburgh, UK | |
Public research university in Edinburgh, Scotland, with a medical school, the Institute of Genetics and Cancer and the Roslin Institute for animal sciences. | Talk Wed Jan 27 11:30–13:00 Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes AI in drug discovery & diagnostics Talk Wed Jan 27 16:30–17:00 Four Nations Data Linkage in Longitudinal Research - Opportunities and Challenges What it takes to link long-running population studies across England, Scotland, Wales and Northern Ireland into richer research datasets. Talk Wed Jan 27 17:00–17:30 Beyond the Majority: Rethinking Treatment for Rare Ovarian Cancer Subtypes Why rarer ovarian cancer subtypes are understudied, and how genomic insights and newer drugs could improve their treatment. Talk Thu Jan 28 12:00–12:30 Using Epigenetic Signatures to Predict Ageing and Disease Risk How DNA methylation marks can estimate ageing and disease risk, and reveal effects of pollution, smoking and vaping in large cohorts. Talk Thu Jan 28 12:30–13:00 Developing a Clinically Useful Blood Test for Earlier Brain Tumour Diagnosis How a blood test using infrared light could catch brain tumours earlier, and what good diagnostic accuracy means in practice. Talk Thu Jan 28 14:10–14:40 3D Genome Organisation and Gene Regulation: Understanding the Non-Coding Genome How the three-dimensional folding of chromosomes brings distant control regions into contact with genes, and what this reveals about non-coding DNA. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease |
Find buyers in AI in drug discovery & diagnostics
Tell us what you sell and we’ll find the people at organizations working on AI in drug discovery & diagnostics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse FoG London 2027 by
Organization type
Topic
- Genomic medicine & rare disease 54
- Cancer genomics & diagnostics 31
- AI in drug discovery & diagnostics 43
- Biodata & bioinformatics 33
- Single-cell genomics 24
- Spatial biology 19
- Multi-omics & proteomics 31
- Epigenetics & translational omics 16
- Pharmacogenomics & patient stratification 16
- Women’s and children’s health 13
- Cell & gene therapy 18
- Microbiome & pathogen genomics 17
- Plant & agricultural genomics 13
- Population & social genomics 23
Exhibit hall
Everyone
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction